Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135141) titled 'Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity' on Aug. 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Beijing Friendship Hospital
Condition:
Severe Obesity
Intervention:
Drug: Sleeve gastrectomy plus early mazdutide initiation
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 30, 2025
Target Sample Size: 256
Countries of Recruitment:
China
To know more, visit https://clinica...